Search

everythinglearnresearchcommunity

for

Search:↓

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

Inositol was more effective than Metformin in treating symptoms of PCOS in women.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

All types of Platelet-Rich Plasma (PRP) can treat hair loss, but homologous PRP works best due to its higher platelet count and growth factors from multiple donors.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Hair changes can indicate systemic diseases or medication effects.

Women with acne have lower levels of a specific hormone marker than women without acne.

Possible link between androgens and COVID-19 severity; more research needed.

Two gene variations, rs6493497 and rs7176005, may be linked to female hair loss in Chinese people.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Women with PCOS can lead healthy lives with proper diagnosis and treatment.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

Letrozole is better for single follicle development and endometrial thickness in PCOS, with no significant difference in pregnancy rates compared to clomiphene.